|
Astrazeneca Wins Dismissal of Verus's Lawsuit Over Children's Asthma Drug
Bloomberg The London-based drugmaker agreed in 2007 to pay more than $310 million to Verus for its pediatric asthma-medicines program. Under the deal, Verus got $30 … |
View full post on asthma – Google News